🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase III multi-centre study in three periods: the first period i...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00416520
Approximately 207 hyperphosphatemic CKD patients not on dialysis will be en...
Status
Terminated
Location
Universitätsklinik für Innere Medizin, Klinische Abteilung für Nephrologie und Hämodialyse
Start Date
2009-01
Trial ID
NCT00833768
Treatments Being Tested
FGF-23 is a newly described protein that is an important regulator of phosp...
Status
Completed
Location
UCLA
Start Date
2009-10
Trial ID
NCT00999037
Treatments Being Tested
The purpose of this clinical study is to compare the effects of Genz-644470...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00853242
Treatments Being Tested
This study is a randomized study designed as a 2x2 cross-over in two period...
Status
Completed
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT02965053
To evaluate the superiority to placebo, dose-responsibility and safety....
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00505037
Treatments Being Tested
The objective of this study is to investigate the potential GLP-1-mediated ...
Status
Completed
Location
Steno Diabetes Center Copenhagen, Gentofte Hospital
Start Date
2018-09-01
Trial ID
NCT03739268
This Phase 3, 26-week, open label study with a 12-week, placebo-controlled,...
Status
Completed
Location
Site 529
Start Date
2018-01-08
Trial ID
NCT03427125
Treatments Being Tested
Objective: In hyperphosphatemic pediatric participants with chronic kidney ...
Status
Completed
Location
Investigational Site Number 8003
Start Date
2012-05
Trial ID
NCT01574326
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled study to evaluate th...
Status
Completed
Location
Nephrology Consultants, LLC
Start Date
2019-02-28
Trial ID
NCT03824587
Treatments Being Tested